112 related articles for article (PubMed ID: 2320782)
21. Steady-state plasma and bronchopulmonary characteristics of clarithromycin extended-release tablets in normal healthy adult subjects.
Gotfried MH; Danziger LH; Rodvold KA
J Antimicrob Chemother; 2003 Sep; 52(3):450-6. PubMed ID: 12888589
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics and mammary residual depletion of erythromycin in healthy lactating ewes.
Goudah A; Sher Shah S; Shin HC; Shim JH; Abd El-Aty AM
J Vet Med A Physiol Pathol Clin Med; 2007 Dec; 54(10):607-11. PubMed ID: 18045347
[TBL] [Abstract][Full Text] [Related]
23. Hyaluronate in bronchoalveolar lavage fluid in sarcoidosis and its relationship to alveolar cell populations.
Eklund A; Hällgren R; Blaschke E; Engström-Laurent A; Persson U; Svane B
Eur J Respir Dis; 1987 Jul; 71(1):30-6. PubMed ID: 2820777
[TBL] [Abstract][Full Text] [Related]
24. Tobramycin penetration into epithelial lining fluid of patients with pneumonia.
Carcas AJ; García-Satué JL; Zapater P; Frías-Iniesta J
Clin Pharmacol Ther; 1999 Mar; 65(3):245-50. PubMed ID: 10096256
[TBL] [Abstract][Full Text] [Related]
25. [Alveolar macrophages and antibiotics. Review].
Voisin C; Carré P; Piva F; Wallaert B
Pathol Biol (Paris); 1987 Dec; 35(10 Pt 2):1412-7. PubMed ID: 3325907
[TBL] [Abstract][Full Text] [Related]
26. Human alveolar macrophages: comparison of phagocytic ability, glucose utilization, and ultrastructure in smokers and nonsmokers.
Harris JO; Swenson EW; Johnson JE
J Clin Invest; 1970 Nov; 49(11):2086-96. PubMed ID: 4319967
[TBL] [Abstract][Full Text] [Related]
27. [Role of alveolar macrophages and neutrophils in the defense system against infection of Pseudomonas aeruginosa in the respiratory tract and the effect of derivative of muramyl dipeptide].
Maeda M; Ozaki T; Yasuoka S; Ogura T
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Jan; 28(1):135-42. PubMed ID: 2355674
[TBL] [Abstract][Full Text] [Related]
28. Immunoreactive prostaglandin production by equine monocytes and alveolar macrophages and concentrations of PGE2 and PGF in bronchoalveolar lavage fluid.
Watson ED; Mair TS; Sweeney CR
Res Vet Sci; 1990 Jul; 49(1):88-91. PubMed ID: 2382063
[TBL] [Abstract][Full Text] [Related]
29. [Ultrastructure of pulmonary alveolar macrophages in peroral exposure to nitrosodimethylamine].
Fetisov VV; Litvinov NN; Gasimova ZM
Biull Eksp Biol Med; 1987 Jan; 103(1):114-7. PubMed ID: 3801639
[TBL] [Abstract][Full Text] [Related]
30. Inhalation of high concentrations of low toxicity dusts in rats results in impaired pulmonary clearance mechanisms and persistent inflammation.
Warheit DB; Hansen JF; Yuen IS; Kelly DP; Snajdr SI; Hartsky MA
Toxicol Appl Pharmacol; 1997 Jul; 145(1):10-22. PubMed ID: 9221819
[TBL] [Abstract][Full Text] [Related]
31. Effects of anaerobiosis upon morphology and energy metabolism of alveolar macrophages cultured in gas phase.
Cazin M; Paluszezak D; Bianchi A; Cazin JC; Aerts C; Voisin C
Eur Respir J; 1990 Oct; 3(9):1015-22. PubMed ID: 2289548
[TBL] [Abstract][Full Text] [Related]
32. Effect of treatment with erythromycin on bronchoalveolar lavage fluid cell populations in foals.
Lakritz J; Wilson WD; Watson JL; Hyde DM; Mihalyi J; Plopper CG
Am J Vet Res; 1997 Jan; 58(1):56-61. PubMed ID: 8989497
[TBL] [Abstract][Full Text] [Related]
33. Pulmonary disposition of erythromycin, azithromycin, and clarithromycin in foals.
Suarez-Mier G; Giguère S; Lee EA
J Vet Pharmacol Ther; 2007 Apr; 30(2):109-15. PubMed ID: 17348895
[TBL] [Abstract][Full Text] [Related]
34. Role of alveolar macrophage chemotaxis and phagocytosis in pulmonary clearance responses to inhaled particles: comparisons among rodent species.
Warheit DB; Hartsky MA
Microsc Res Tech; 1993 Dec; 26(5):412-22. PubMed ID: 8286787
[TBL] [Abstract][Full Text] [Related]
35. The productive infection of alveolar macrophages by simian immunodeficiency virus.
Ringler DJ; Wyand MS; Walsh DG; MacKey JJ; Sehgal PK; Daniel MD; Desrosiers RC; King NW
J Med Primatol; 1989; 18(3-4):217-26. PubMed ID: 2474655
[TBL] [Abstract][Full Text] [Related]
36. [Erythromycin penetration into the cerebrospinal fluid of patients].
Imshenetskaia VF
Antibiotiki; 1976 Nov; 21(11):1002-4. PubMed ID: 1020930
[TBL] [Abstract][Full Text] [Related]
37. Josamycin pulmonary penetration determined by broncho-alveolar lavage in man.
Panteix G; Harf R; de Montclos H; Verdier MF; Gaspar A; Leclercq M
J Antimicrob Chemother; 1988 Dec; 22(6):917-21. PubMed ID: 3243740
[TBL] [Abstract][Full Text] [Related]
38. Pulmonary alveolar macrophage response to hyperbaric carbon monoxide exposure.
Roloff MV; D'Addario AP; Buffum EJ
Undersea Biomed Res; 1978 Mar; 5(1):15-23. PubMed ID: 636071
[TBL] [Abstract][Full Text] [Related]
39. [Survival in gazeous phase and reconstitution "in vitro" of the natural microenvironment of alveolar macrophages].
Voisin C; Aerts C; Tonnel AB; Houdret JL; Ramon P
Pathol Biol (Paris); 1975 Jun; 23(6):453-9. PubMed ID: 1105345
[TBL] [Abstract][Full Text] [Related]
40. Accumulation of pefloxacin in the lower respiratory tract demonstrated by bronchoalveolar lavage.
Panteix G; Harf R; Desnottes JF; Gosselet H; Leclercq M; Diallo N; Couprie N; Desbos A; Perrin Fayolle M; Ballereau M
J Antimicrob Chemother; 1994 May; 33(5):979-85. PubMed ID: 8089071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
